William H. Wilson, M.D.

Research Projects:

1. Pfizer Pharmaceuticals: Effects of Ziprasidone treatment on brain metabolism associated with thought disorder and auditory attention in schizophrenia, 10/16/2001 to 10/15/2003.
2. Stanley Foundation: Treatment of chronic drug resistant schizophrenia with low doses of clozapine, 07/01/1996 to 06/30/1998.
3. Zeneca Pharmacueticals: A Multicenter, open, randomized comparison of ICI240,636 and usual care on health outcomes in subjects with schizophrenia and schizoaffective disorder (Oregon site), 07/01/1995 to 06/30/1998.
4. Abbott Pharmaceuticals: Use of Anticonvulsants for Clozapine Induced Seizures, 07/01/1993 to 06/30/1994.
5. Sandoz Pharmaceuticals: Clinical Review of Clozapine Treatment in a State Hospital, 07/01/1993 to 06/30/1994.
6. National Institute for Mental Health: Pharmacological Strategies in Treatment Resistant Schizophrenia, 07/01/1989 to 06/30/1993.
7. Commonwealth of Pennsylvania: Psychiatric Residents in Community Treatment Teams, 07/01/1988 to 06/30/1990.
8. State of Oregon: Evaluation of Atypical Antipsychotic Project, 04/01/2000 to 03/30/2002.

Faculty Page

Research Projects